Related Experiment Video
Updated: Sep 25, 2025

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
Emerging Roles of Inflammasomes in Cardiovascular Diseases
Yingnan Liao1, Kui Liu2, Liyuan Zhu1
1Xiamen Key Laboratory of Cardiovascular Disease, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Insights
Inflammasomes, key immune sensors, drive cardiovascular diseases like atherosclerosis. Targeting the NLRP3 inflammasome and IL-1β offers promising therapeutic strategies for these conditions.
Area of Science:
- Immunology
- Cardiology
- Molecular Biology
Background:
- Cardiovascular diseases (CVDs) are the primary global cause of death.
- Inflammasomes are innate immune complexes activated by CVD risk factors.
- Inflammasomes regulate caspase-1 and pro-inflammatory cytokines (IL-1β, IL-18), impacting disease progression.
Purpose of the Study:
- To review inflammasome activation and regulation mechanisms.
- To elucidate the role of inflammasomes in cardiovascular diseases (atherosclerosis, myocardial infarction, heart failure).
- To summarize research on targeting NLRP3 inflammasome and IL-1β for therapeutic intervention.
Main Methods:
- Literature review focusing on inflammasome research in cardiovascular contexts.
- Analysis of studies on NLRP1, NLRP3, NLRC4, and AIM2 inflammasomes.
- Examination of therapeutic strategies targeting NLRP3 and IL-1β.
Main Results:
- Inflammasomes are crucial in the pathogenesis of atherosclerosis, myocardial infarction, and heart failure.
- NLRP3 inflammasome is extensively studied for its role in immune response and disease.
- Targeting NLRP3 inflammasome and IL-1β shows potential for CVD intervention.
Conclusions:
- Inflammasome activation is a significant factor in cardiovascular disease development.
- The NLRP3 inflammasome and its downstream cytokine IL-1β are key therapeutic targets.
- Further research into inflammasome inhibition may lead to novel treatments for cardiovascular conditions.
Abstract:
Cardiovascular diseases are known as the leading cause of morbidity and mortality worldwide. As an innate immune signaling complex, inflammasomes can be activated by various cardiovascular risk factors and regulate the activation of caspase-1 and the production and secretion of proinflammatory cytokines such as IL-1β and IL-18. Accumulating evidence supports that inflammasomes play a pivotal role in the progression of atherosclerosis, myocardial infarction, and heart failure. The best-known inflammasomes are NLRP1, NLRP3, NLRC4, and AIM2 inflammasomes, among which NLRP3 inflammasome is the most widely studied in the immune response and disease development. This review focuses on the activation and regulation mechanism of inflammasomes, the role of inflammasomes in cardiovascular diseases, and the research progress of targeting NLRP3 inflammasome and IL-1β for related disease intervention.
More Related Videos
Related Concept Videos
Inflammation
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Inflammatory Response I: Vascular and Cellular
Coronary Artery Disease II: Pathophysiology

